Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial-Reference-Cited by-同舟云学术

Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial

Published:2016-08 Issue:8 Volume:17 Page:1147-1157
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Goto Koichi,Ohe Yuichiro,Shibata Taro,Seto Takashi,Takahashi Toshiaki,Nakagawa Kazuhiko,Tanaka Hiroshi,Takeda Koji,Nishio Makoto,Mori Kiyoshi,Satouchi Miyako,Hida Toyoaki,Yoshimura Naruo,Kozuki Toshiyuki,Imamura Fumio,Kiura Katsuyuki,Okamoto Hiroaki,Sawa Toshiyuki,Tamura Tomohide

Funder

National Cancer Center Research and Development Fund

Grant-in-Aid for Cancer Research

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Management of small-cell cancer of the lung;Hansen;Lancet,1992

2. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

3. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy;Giaccone;J Clin Oncol,1988

4. Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy;Kim;Cancer,2008

5. Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy;Postmus;Eur J Cancer Clin Oncol,1987

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktuelle Standards und vielversprechende Innovationen in der medikamentösen Zweitlinientherapie des metastasierten kleinzelligen Lungenkarzinoms (ED-SCLC);Die Onkologie;2024-08-02

2. Solid Lipid Nanoparticles for the Delivery of Plant-derived Bioactive Compounds in the Treatment of Cancer Disorders – A Review;Journal of Natural Remedies;2024-07-31

3. The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics;Genes;2024-05-27

4. Enhancing Curcumin’s therapeutic potential in cancer treatment through ultrasound mediated liposomal delivery;Scientific Reports;2024-05-07

5. Epigambogic Acid A from Gamboge Stalk Suppresses Non-Small Cell Lung Cancer Progression by Attenuating DIRC1 Expression;J BIOL REG HOMEOS AG;2024